Amir Moheet

Amir Moheet

Auto-generated profile, based on publicly available information

Amir Moheet

Department of Medicine, University of Minnesota, Minneapolis, MN, USA

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2015 in Annals of the New York Academy of Sciences
Verified
Journal Article
Open access
PDF file
AMAmir Moheet
Amir Moheet
SMSilvia Mangia
Silvia Mangia
ESElizabeth R. Seaquist
Elizabeth R. Seaquist
Both type 1 and type 2 diabetes have been associated with reduced performance on multiple domains of cognitive function and with structural abnormalities in the brain. With an aging population and a growing epidemic of diabetes, central nervous system–related complications of diabetes are expected to rise and could have challenging future public health implications. In this review, we will discuss the brain structural and functional changes that have been associated with type 1 and type 2 diabetes. Diabetes duration and glycemic control may play important roles in the development of cognitive impairment in diabetes, but the exact underlying pathophysiological mechanisms causing these changes in cognition and structure are not well understood. Future research is needed to better understand the natural history and the underlying mechanisms, as well as to identify risk factors that predict who is at greatest risk of developing cognitive impairment. This information will lead to the development of new strategies to minimize the impact of diabetes on cognitive function.

1 April 2011 in American Journal of Cardiovascular Drugs
Verified
Journal Article
Closed access
PDF file
Adrian V. HernandezAdrian V. Hernandez
Adrian V. Hernandez
AUAli Usmani
Ali Usmani
ARAnitha Rajamanickam
Anitha Rajamanickam
AMA. Moheet
A. Moheet

1 October 2019 in Journal of Cystic Fibrosis
Verified
Journal Article
Open access
AGAndrea Granados
Andrea Granados
CCChristine L. Chan
Christine L. Chan
KOKatie Larson Ode
Katie Larson Ode
AMAmir Moheet
Amir Moheet
AMAntoinette Moran
Antoinette Moran
RHReinhard Holl
Reinhard Holl
Cystic fibrosis related diabetes (CFRD) is a distinct form of diabetes that is associated with significantly increased morbidity and mortality in the CF population. The primary etiology is relative insulin insufficiency secondary to destruction of pancreatic islets, and to other factors that affect the function of the remaining beta cells. The prevalence of CFRD increases markedly with age and more than half of CF adults develop the disease. As the initial presentation of CFRD may be clinically silent, annual screening is recommended starting at least by the age of 10 with an oral glucose tolerance test (OGTT). The importance of an early diagnosis is based on the association of diabetes and abnormal glucose tolerance with worse health outcomes in patients with CF, and evidence that early treatment of diabetes improves prognosis. This review presents a concise overview of the current understanding of CFRD pathogenesis, natural history, screening and diagnosis.

22 January 2019 in Endocrine Reviews
Verified
Journal Article
Open access
PDF file
SSSarah Stanley
Sarah Stanley
AMAmir Moheet
Amir Moheet
ESElizabeth R Seaquist
Elizabeth R Seaquist
Glucose homeostasis requires an organism to rapidly respond to changes in plasma glucose concentrations. Iatrogenic hypoglycemia as a result of treatment with insulin or sulfonylureas is the most common cause of hypoglycemia in humans and is generally only seen in patients with diabetes who take these medications. The first response to a fall in glucose is the detection of impending hypoglycemia by hypoglycemia-detecting sensors, including glucose-sensing neurons in the hypothalamus and other regions. This detection is then linked to a series of neural and hormonal responses that serve to prevent the fall in blood glucose and restore euglycemia. In this review, we discuss the current state of knowledge about central glucose sensing and how detection of a fall in glucose leads to the stimulation of counterregulatory hormone and behavior responses. We also review how diabetes and recurrent hypoglycemia impact glucose sensing and counterregulation, leading to development of impaired awareness of hypoglycemia in diabetes.

1 January 2020 in Journal of Cystic Fibrosis
Verified
Journal Article
Closed access
THTasma Harindhanavudhi
Tasma Harindhanavudhi
QWQi Wang
Qi Wang
JDJordan Dunitz
Jordan Dunitz
AMAntoinette Moran
Antoinette Moran
AMAmir Moheet
Amir Moheet

23 July 2015 in Neurochemical Research
Verified
Journal Article
Closed access
PDF file
GOGulin Oz
Gulin Oz
MDMauro DiNuzzo
Mauro DiNuzzo
AKAnjali Kumar
Anjali Kumar
AMAmir Moheet
Amir Moheet
ESElizabeth R. Seaquist
Elizabeth R. Seaquist